Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boyd

Showing results (521-530 of 565) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|March 15, 2000
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
Biochemistry|November 5, 2011
Discovery of amino acid motifs for thrombin cleavage and validation using a model substrateNatasha M Ng, James D Pierce, Geoffrey I Webb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersenSusan O'Brien, Joseph O Moore, Thomas E Boyd, et al.
Molecular Immunology|August 22, 2007
Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitorFelicity K Kerr, Adele R Thomas, Lakshmi C Wijeyewickrema, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial CarcinomaWassim Abida, Matthew I Milowsky, Irina Ostrovnaya, et al.
The Journal of Organic Chemistry|January 10, 1997
Recognition of Bipyridinium-Based Derivatives by Hydroquinone- and/or Dioxynaphthalene-Based Macrocyclic Polyethers: From Inclusion Complexes to the Self-Assembly of [2]CatenanesMasumi Asakawa, Peter R. Ashton, Sue E. Boyd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugsJune M McKoy, E Allison Lyons, Eniola Obadina, et al.
Neuroimage|May 9, 2017
High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlasZ M Saygin, D Kliemann, J E Iglesias, et al.
Journal of Medicinal Chemistry|April 13, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 3. ImidazolylmethylthiophenesR E Boyd, J B Press, C R Rasmussen, et al.
Clinical Genetics|January 1, 1996
Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: Clinical assessmentA J Barnicoat, J L Bonneau, E Boyd, et al.
Pageof 57

Showing results (521-530 of 565) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|March 15, 2000
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
Biochemistry|November 5, 2011
Discovery of amino acid motifs for thrombin cleavage and validation using a model substrateNatasha M Ng, James D Pierce, Geoffrey I Webb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersenSusan O'Brien, Joseph O Moore, Thomas E Boyd, et al.
Molecular Immunology|August 22, 2007
Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitorFelicity K Kerr, Adele R Thomas, Lakshmi C Wijeyewickrema, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial CarcinomaWassim Abida, Matthew I Milowsky, Irina Ostrovnaya, et al.
The Journal of Organic Chemistry|January 10, 1997
Recognition of Bipyridinium-Based Derivatives by Hydroquinone- and/or Dioxynaphthalene-Based Macrocyclic Polyethers: From Inclusion Complexes to the Self-Assembly of [2]CatenanesMasumi Asakawa, Peter R. Ashton, Sue E. Boyd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugsJune M McKoy, E Allison Lyons, Eniola Obadina, et al.
Neuroimage|May 9, 2017
High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlasZ M Saygin, D Kliemann, J E Iglesias, et al.
Journal of Medicinal Chemistry|April 13, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 3. ImidazolylmethylthiophenesR E Boyd, J B Press, C R Rasmussen, et al.
Clinical Genetics|January 1, 1996
Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: Clinical assessmentA J Barnicoat, J L Bonneau, E Boyd, et al.
Pageof 57